Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Anti-Microbialvior BioteQ Co has a quick ratio of 47.67. It generally indicates good short-term financial strength.
The historical rank and industry rank for Anti-Microbialvior BioteQ Co's Quick Ratio or its related term are showing as below:
ROCO:6864'
s Quick Ratio Range Over the Past 10 Years
Min: 11.87 Med: 23.76 Max: 528.86
Current: 47.67
During the past 8 years, Anti-Microbialvior BioteQ Co's highest Quick Ratio was 528.86. The lowest was 11.87. And the median was 23.76.
ROCO:6864's Quick Ratio is ranked better than 98.3% of 1411
companies
in the Biotechnology industry
Industry Median: 3.59
vs ROCO:6864: 47.67
Anti-Microbialvior BioteQ Co (ROCO:6864) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Anti-Microbialvior BioteQ Co Quick Ratio Related Terms
Anti-Microbialvior BioteQ Co Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6864 vs VRTX, REGN, ALNY: Quick Ratio Comparison
For the Biotechnology subindustry, Anti-Microbialvior BioteQ Co's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Anti-Microbialvior BioteQ Co Quick Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Anti-Microbialvior BioteQ Co's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Anti-Microbialvior BioteQ Co's Quick Ratio falls into.
Anti-Microbialvior BioteQ Co Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Anti-Microbialvior BioteQ Co (ROCO:6864) has a Quick Ratio of 47.67 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Anti-Microbialvior BioteQ Co and its competitors. This is 101% above median its historical median of 23.76. Over the past decade, Anti-Microbialvior BioteQ Co's Quick Ratio has ranged from 11.87 to 528.86. According to the industry distribution chart, Anti-Microbialvior BioteQ Co ranks #24 out of 1411 companies in the Biotechnology industry, placing it in the top 1.7%.
Is Anti-Microbialvior BioteQ Co's Quick Ratio too high?
Anti-Microbialvior BioteQ Co's current Quick Ratio of 47.67 is 101% above median its 10-year median of 23.76. Over the past 10 years, this metric has ranged from a low of 11.87 to a high of 528.86. The Biotechnology industry median Quick Ratio is 3.59. Anti-Microbialvior BioteQ Co's value of 47.67 is 1227.9% above this industry median. Based on the distribution chart, Anti-Microbialvior BioteQ Co ranks #24 out of 1411 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Anti-Microbialvior BioteQ Co has a GF Score™ of 65/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Anti-Microbialvior BioteQ Co's Quick Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Anti-Microbialvior BioteQ Co ranks #24 out of 1411 companies for Quick Ratio. This places Anti-Microbialvior BioteQ Co in the top 2% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 3.59. Anti-Microbialvior BioteQ Co's value of 47.67 is 1227.9% above this benchmark. Historically, Anti-Microbialvior BioteQ Co's own Quick Ratio has ranged from 11.87 to 528.86 over the past decade. While the company's 10-year median is 23.76 vs. the industry median of 3.59, Anti-Microbialvior BioteQ Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Biotechnology company?
The median Quick Ratio among Biotechnology companies is 3.59, based on 1,411 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Anti-Microbialvior BioteQ Co's current Quick Ratio of 47.67 is 1227.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Anti-Microbialvior BioteQ Co and its competitors. For the Biotechnology industry, the median Quick Ratio is 3.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Anti-Microbialvior BioteQ Co's current Quick Ratio is 47.67, which is 101% above median its own 10-year median of 23.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anti-Microbialvior BioteQ Co stock overvalued right now?
Based on GuruFocus' analysis, Anti-Microbialvior BioteQ Co (ROCO:6864) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$25.48, compared to a current price of NT$42.90 — trading 68.4% above its estimated fair value. The current Quick Ratio is 47.67, which is 101% above median its 10-year median of 23.76 and 1227.9% above the Biotechnology industry median of 3.59. Anti-Microbialvior BioteQ Co's overall GF Score™ is 65/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Anti-Microbialvior BioteQ Co (ROCO:6864), the current Quick Ratio is 47.67 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Anti-Microbialvior BioteQ Co (ROCO:6864) Overvalued in 2026?
Based on GuruFocus' analysis, Anti-Microbialvior BioteQ Co stock appears to be overvalued.
The current stock price of NT$42.90 is trading 68.4% above its estimated GF Value™ of NT$25.48.
GuruFocus considers Anti-Microbialvior BioteQ Co to be Significantly Overvalued.
Key valuation signals for ROCO:6864:
Quick Ratio: 47.67 (101% above median its 10-year median of 23.76)
GF Value™: NT$25.48 vs. price of NT$42.90 (68.4% above fair value)
Industry Position: 1227.9% above the Biotechnology median (#24 of 1411)
No single metric tells the full story. See the ROCO:6864 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6864 has been successfully added to your 
